Muscle wasting in disease: molecular mechanisms and promising therapies
The DOI matches its Crossref record; 255 of the 257 references it cites were found in a registry or an index.
Abstract
Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence also indicates that RT can effectively mitigate LM or skeletal muscle mass loss associated with dietary interventions (75) and in response to disease states (76).This occurs independently of reductions in body weight and fat mass.”
From Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? (2024) · cites this paper as [75]
In the citing paper
“The muscle atrophy also occurs in cachexia, a comorbidity of abnormal conditions such as cancer, AIDS, congestive heart failure and chronic obstructive pulmonary disease, also occurs in sarcopenia, a decreases in muscle mass and strength associated with aging [61] .”
From Alternative Medicine: New Ways to Treat Diseases and Therapies (2021) · cites this paper as [61]
In the citing paper
“MuRF1 ubiquitinates several muscle structural proteins, including troponin I, myosin heavy chains, actin, myosin-binding protein C, and myosin light chains 1 and 242.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [42]
In the citing paper
“Because muscle loss requires the activation of transcription‐dependent programme controlled by the regulation of a subset of genes named atrophy‐related genes or atrogenes,36 we monitored several atrogenes mRNAs”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [36]
In the citing paper
“Skeletal muscle mass is controlled by a fine balance between protein synthesis and protein degradation processes triggered by changes in physical activity11,14,15, yet the intrinsic muscular signaling networks driving muscle mass loss particularly during the early phase of muscle disuse remain unclear.”
From Disuse-associated loss of the protease Lonp1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength (2022) · cites this paper as [14]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Self-citationTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Self-citation
Research works printed but not linked: 1
- Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35–46 (2007). · DOI · Paper page
Cited by
Items 201–300 of 1,000
Twist1 Activation in Muscle Progenitor Cells Causes Muscle Loss Akin to Cancer Cachexia
Parajuli, P., Kumar, S., Loumaye, A., Singh, P., Eragamreddy, S., Nguyen, T. L., Ozkan, S., Razzaque, M. S., Prunier, C., Thissen, J.-P., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.05.026 · Cited by 58
Sureda-Gómez, M., Martín-Durán, J. M., & Adell, T. (2016) · Development · doi:10.1242/dev.135152 · Cited by 58
Morozzi, G., Beccafico, S., Bianchi, R., Riuzzi, F., Bellezza, I., Giambanco, I., Arcuri, C., Minelli, A., & Donato, R. (2017) · Cell Death & Differentiation · doi:10.1038/cdd.2017.132 · Cited by 58
ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation
Lee, D., Takayama, S., & Goldberg, A. L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809934115 · Cited by 58
“Protein breakdown rates normally are low in skeletal muscle, except during atrophy when the UPS is activated and accounts for most of increased protein degradation (10).”
BackgroundInfluentialSelf-citationCarrillo, N., Malicdan, M. C. V., Leoyklang, P., Shrader, J. A., Joe, G. O., Slota, C., Perreault, J., Heiss, J. D., Class, B., Liu, C., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01259-x · Cited by 65
Yin, L., Chen, X., Li, N., Jia, W., Wang, N., Hou, B., Yang, H., Zhang, L., Qiang, G., Yang, X., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110977 · Cited by 61
Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
Huber, M. B., Wacker, M. E., Vogelmeier, C. F., & Leidl, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132670 · Cited by 59
Coordinate regulation of autophagy and the ubiquitin proteasome system by MTOR
Zhao, J., & Goldberg, A. L. (2016) · Autophagy · doi:10.1080/15548627.2016.1205770 · Cited by 63
Self-citationACE2, angiotensin 1-7 and skeletal muscle: review in the era of COVID-19
Yamamoto, K. I., Takeshita, H., & Rakugi, H. (2020) · Clinical Science · doi:10.1042/cs20200486 · Cited by 63
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Choi, E., & Koo, T. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.04.002 · Cited by 59
Su, Z., (虎力), L. H., Cheng, J., Klein, J. D., Hassounah, F., Cai, H., Li, M., Wang, H., & Wang, X. H. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00175.2015 · Cited by 59
Therapeutic Benefit of Autophagy Modulation in Pompe Disease
Lim, J., Sun, B., Puertollano, R., & Raben, N. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.025 · Cited by 63
Deng, C., Lu, C., Wang, K., Chang, M., Shen, Y., Yang, X., Sun, H., Yao, X., Qiu, C., & Xu, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1344276 · Cited by 64
The role of TGF-β signaling in muscle atrophy, sarcopenia and cancer cachexia
Lan, X., Deng, C., Wang, Q., Zhao, L., Jiao, B., & Xiang, Y. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114513 · Cited by 66
Moreau, J., Ordan, M., Barbe, C., Mazza, C., Perrier, M., Botsen, D., Brasseur, M., Portefaix, C., Renard, Y., Tallière, B., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2238 · Cited by 60
Redox Control of Proteolysis During Inactivity-Induced Skeletal Muscle Atrophy
Powers, S. K., Ozdemir, M., & Hyatt, H. W. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8000 · Cited by 58
Borges, T. C., Gomes, T. L. N., Pichard, C., Laviano, A., & Pimentel, G. D. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.05.005 · Cited by 56
Glabridin Inhibits Dexamethasone-Induced Muscle Atrophy
Yoshioka, Y., Kubota, Y., Samukawa, Y., Yamashita, Y., & Ashida, H. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.02.006 · Cited by 54
lncRNA Chronos is an aging-induced inhibitor of muscle hypertrophy
Neppl, R. L., Wu, C., & Walsh, K. X. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201612100 · Cited by 54
Drescher, C., Konishi, M., Ebner, N., & Springer, J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.033 · Cited by 53
Files, D. C., Sanchez, M. A., & Morris, P. E. (2015) · Critical Care · doi:10.1186/s13054-015-0979-5 · Cited by 58
Son, Y. H., Jang, E. J., Kim, Y. W., & Lee, J. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.002 · Cited by 60
Wiederstein, J. L., Nolte, H., Günther, S., Piller, T., Baraldo, M., Kostin, S., Bloch, W., Schindler, N., Sandri, M., Blaauw, B., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.136 · Cited by 52
“Balanced regulation of protein synthesis and breakdown is crucial to maintain skeletal muscle function (Cohen et al., 2015; Schiaffino and Reggiani, 2011).”
BackgroundPerakakis, N., Mougios, V., Fatouros, I., Siopi, A., Draganidis, D., Peradze, N., Ghaly, W., & Mantzoros, C. S. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01056 · Cited by 52
Davey, J. R., Watt, K. I., Parker, B. L., Chaudhuri, R., Ryall, J. G., Cunningham, L., Qian, H., Sartorelli, V., Sandri, M., Chamberlain, J., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85477 · Cited by 51
“One strategy for potentially preventing or reversing sarcopenic muscle wasting is to manipulate the transforming growth factor-β (TGF-β) signaling network in muscle to shift the processes controlling protein turnover in favor of conservation and/or accretion (9, 10).”
BackgroundShin, J. E., Park, S. J., Ahn, S. I., & Choung, S.-Y. (2020) · Nutrients · doi:10.3390/nu12113362 · Cited by 52
The role of myokines in cancer: crosstalk between skeletal muscle and tumor
Park, S.-Y., Hwang, B.-O., & Song, N. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0064 · Cited by 56
Emerging role and function of Hippo-YAP/TAZ signaling pathway in musculoskeletal disorders
Han, J., Zhang, J., Zhang, X., Luo, W., Liu, L., Zhu, Y., Liu, Q., & Zhang, X. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-04011-9 · Cited by 63
CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice
Li, J., Wang, L., Hua, X., Tang, H., Chen, R., Yang, T., Das, S., & Xiao, J. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.03.005 · Cited by 55
Adams, V., Bowen, T. S., Werner, S., Barthel, P., Amberger, C., Konzer, A., Graumann, J., Sehr, P., Lewis, J., Provaznik, J., et al. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12448 · Cited by 51
“In this process, the activation of the muscle ring finger protein 1 (MuRF1) is believed to drive the poly-ubiquitylation of proteins scheduled for degradation via the UPS.8,9 The central role of MuRF1 in modulating muscle mass is further supported by observations of upregulated MuRF1 expression in numerous clinical co…”
BackgroundDaidzein alleviates cisplatin‐induced muscle atrophy by regulating Glut4/ AMPK / FoxO pathway
Zhang, H., Chi, M., Chen, L., Sun, X., Wan, L., Yang, Q., & Guo, C. (2021) · Phytotherapy Research · doi:10.1002/ptr.7132 · Cited by 56
Oláh, G., Szczesny, B., Brunyánszki, A., López-García, I. A., Gerö, D., Radák, Z., & Szabo, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0134227 · Cited by 51
Gregorich, Z. R., Peng, Y., Cai, W., Jin, Y., Wei, L., Chen, A. J., McKiernan, S. H., Aiken, J. M., Moss, R. L., Diffee, G. M., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00244 · Cited by 51
Quorum sensing molecules as a novel microbial factor impacting muscle cells
Spiegeleer, A. D., Elewaut, D. S., Noortgate, N. J. V. D., Janssens, Y., Debunne, N., Langenhove, S. V., Govindarajan, S., Spiegeleer, B. M. J. D., & Wynendaele, E. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165646 · Cited by 53
The Role of Lonp1 on Mitochondrial Functions during Cardiovascular and Muscular Diseases
Zanini, G., Selleri, V., Malerba, M., Solodka, K., Sinigaglia, G., Nasi, M., Mattioli, A. V., & Pinti, M. (2023) · Antioxidants · doi:10.3390/antiox12030598 · Cited by 59
Shum, A. M. Y., Poljak, A., Bentley, N. L., Turner, N. A., Tan, T. C., & Polly, P. (2018) · Oncotarget · doi:10.18632/oncotarget.25146 · Cited by 53
Ding, S., Dai, Q., Huang, H., Xu, Y., & Zhong, C. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-1435-3_1 · Cited by 53
IRE1α regulates skeletal muscle regeneration through myostatin mRNA decay
He, S., Fu, T., Yu, Y., Liang, Q., Li, L., Liu, J., Zhang, X., Zhou, Q., Guo, Q., Xu, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143737 · Cited by 54
Papaconstantinou, D., Vretakakou, K., Πασπάλα, Ά., Misiakos, E. P., Charalampopoulos, A. A., Nastos, C., Patapis, P., & Pikoulis, E. A. (2020) · Diseases of the Esophagus · doi:10.1093/dote/doaa002 · Cited by 49
Liu, Y., Bi, X., Zhang, Y., Wang, Y., & Ding, W. (2020) · Laboratory Investigation · doi:10.1038/s41374-019-0355-1 · Cited by 48
Sha, T., Wang, Y., Zhang, Y., Lane, N. E., Li, C., Wei, J., Zeng, C., & Lei, G. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.31558 · Cited by 53
Sun, R., Zhang, S., Hu, W., Lü, X. Q., Lou, N., Zhen-de, Y., Chen, S., Zhang, X., & Yang, H. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00344.2015 · Cited by 54
Molecular Insights into Muscle Homeostasis, Atrophy and Wasting
Scicchitano, B. M., Dobrowolny, G., Sica, G., & Musarò, A. (2018) · Current Genomics · doi:10.2174/1389202919666180101153911 · Cited by 56
Chiu, H., Chiu, C., Yang, R., Chan, D., Liu, S., & Chiang, C. (2018) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12289 · Cited by 51
Myostatin Is Associated With Cognitive Decline in an Animal Model of Alzheimer’s Disease
Lin, Y.-S., Lin, F.-Y., & Hsiao, Y. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1201-y · Cited by 56
Ohlendieck, K., & Swandulla, D. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02623-1 · Cited by 65
Wei, L., Gregorich, Z. R., Lin, Z., Cai, W., Jin, Y., McKiernan, S. H., McIlwain, S., Aiken, J. M., Moss, R. L., Diffee, G. M., et al. (2018) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000124 · Cited by 47
Proteomic serum biomarkers for neuromuscular diseases
Murphy, S., Zweyer, M., Mundegar, R. R., Swandulla, D., & Ohlendieck, K. (2018) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1429923 · Cited by 52
Proline- and Arginine-Rich Peptides as Flexible Allosteric Modulators of Human Proteasome Activity
Giżyńska, M., Witkowska, J., Karpowicz, P., Rostankowski, R., Chocrón, E. S., Pickering, A. M., Osmulski, P. A., Gaczynska, M. E., & Jankowska, E. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01025 · Cited by 49
Jung, H., Kim, S., Kim, I., Lim, J., Park, H.-S., Song, W., Yoo, H. J., Jang, H. C., Kim, K., Park, Y., et al. (2018) · Annals of Geriatric Medicine and Research · doi:10.4235/agmr.18.0046 · Cited by 46
Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer
Lee, J., Liu, S., Dai, K., Huang, Y. M., Li, C., Chen, J. C., Leu, Y., Liu, C., & Chen, Y. (2020) · The Laryngoscope · doi:10.1002/lary.29221 · Cited by 48
Functional Non-coding RNA During Embryonic Myogenesis and Postnatal Muscle Development and Disease
Luo, H., Lv, W., Tong, Q., Jin, J., Xu, Z., & Zuo, B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.628339 · Cited by 63
Sun, H., Sun, J., Li, M., Qian, L., Zhang, L., Huang, Z., Shen, Y., Law, B. Y. K., Liu, L., & Gu, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730070 · Cited by 54
Fucoxanthin rescues dexamethasone induced C2C12 myotubes atrophy
Zhiyin, L., Jinliang, C., Qiunan, C., Yunfei, Y., & Xiao, Q. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111590 · Cited by 54
Yuan, T., Li, W., Zhou, M., Wang, X., Wang, B., & Zhao, Y. (2024) · Advanced Materials · doi:10.1002/adma.202411628 · Cited by 48
The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy
Samant, S. A., Kanwal, A., Pillai, V. B., Bao, R., & Gupta, M. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-10838-5 · Cited by 46
Jang, I.-Y., Jung, H.-W., Lee, C. K., Yu, S. S., Lee, Y. S., & Lee, E. (2018) · Clinical Interventions in Aging · doi:10.2147/cia.s155619 · Cited by 46
Berdeaux, R., & Hutchins, C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00535 · Cited by 59
Kim, J., Grotegut, C. A., Wisler, J. W., Mao, L., Rosenberg, P. B., Rockman, H. A., & Lefkowitz, R. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920310117 · Cited by 49
Ma, W., Cai, Y. M., Shen, Y., Chen, X., Zhang, L., Ji, Y., Chen, Z., Zhu, J., Yang, X., & Sun, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.663384 · Cited by 46
Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene
Ferrara, M., Samaden, M., Ruggieri, E., & Vénéreau, E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.960341 · Cited by 48
You, Z., Huang, X., Xiang, Y., Dai, J., Xu, L., Jiang, J., & Xu, J. (2022) · Theranostics · doi:10.7150/thno.74831 · Cited by 51
Kidney atrophy vs hypertrophy in diabetes: which cells are involved?
Habib, S. L. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1496744 · Cited by 47
Ninfali, C., Siles, L., Darling, D. S., & Postigo, A. A. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky835 · Cited by 52
Association between Dietary Inflammatory Index and Sarcopenia: A Meta-Analysis
Diao, H., Yan, F., He, Q., Li, M., Zheng, Q., Zhu, Q., Fang, F., & Cui, W. (2023) · Nutrients · doi:10.3390/nu15010219 · Cited by 47
Non-coding RNA basis of muscle atrophy
Liu, Q., Deng, J., Qiu, Y., Gao, J., Li, J., Guan, L., Lee, H., Zhou, Q., & Xiao, J. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.010 · Cited by 47
Baribault, C., Ehrlich, K. C., Ponnaluri, V. K. C., Pradhan, S., Lacey, M. R., & Ehrlich, M. (2018) · Epigenetics · doi:10.1080/15592294.2018.1445900 · Cited by 45
Reductive stress in striated muscle cells
Bellezza, I., Riuzzi, F., Chiappalupi, S., Arcuri, C., Giambanco, I., Sorci, G., & Donato, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03476-0 · Cited by 46
Muscle mass assessment in renal disease: the role of imaging techniques
Sabatino, A., D’Alessandro, C., Regolisti, G., Mario, F. D., Guglielmi, G., Bazzocchi, A., & Fiaccadori, E. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims.2020.03.05 · Cited by 52
Lee, E. J., Shaikh, S., Ahmad, K., Ahmad, S. S., Lim, J. H., Park, S., Yang, H. J., Cho, W., Park, S., Lee, Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020876 · Cited by 47
Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation
Goldberg, A. L., Kim, H. T., Lee, D. H., & Collins, G. A. (2021) · Biomolecules · doi:10.3390/biom11060779 · Cited by 42
Self-citationCancer-Associated Cachexia: A Systemic Consequence of Cancer Progression
Biswas, A., & Acharyya, S. (2019) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-030419-033642 · Cited by 47
Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA
Schumann, C., Nguyen, D. X., Norgard, M., Bortnyak, Y., Korzun, T., Chan, S., Lorenz, A. S., Moses, A. S., Albarqi, H. A., Wong, L., et al. (2018) · Theranostics · doi:10.7150/thno.27847 · Cited by 42
Measuring the effects of exercise in neuromuscular disorders: a systematic review and meta-analyses
Stefanetti, R. J., Blain, A. P., Jimenez‐Moreno, C., Errington, L., Ng, Y. S., McFarland, R., Turnbull, D. M., Newman, J. H., & Gorman, G. S. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.15825.1 · Cited by 48
The clinical relevance and mechanism of skeletal muscle wasting
Duan, K., Gao, X., & Zhu, D. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.07.029 · Cited by 47
Role of follistatin in muscle and bone alterations induced by gravity change in mice
Kawao, N., Morita, H., Obata, K., Tatsumi, K., & Kaji, H. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25986 · Cited by 44
Zhao, F., Yu, Y., Liu, W., Zhang, J., Liu, X., Liu, L., & Yin, H. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b05387 · Cited by 41
μ‐Crystallin controls muscle function through thyroid hormone action
Seko, D., Ogawa, S., Li, T., Taimura, A., & Ono, Y. (2015) · The FASEB Journal · doi:10.1096/fj.15-280933 · Cited by 44
The vestibular system is critical for the changes in muscle and bone induced by hypergravity in mice
Kawao, N., Morita, H., Obata, K., Tamura, Y., Okumoto, K., & Kaji, H. (2016) · Physiological Reports · doi:10.14814/phy2.12979 · Cited by 45
MyoScreen, a High-Throughput Phenotypic Screening Platform Enabling Muscle Drug Discovery
Young, J., Margaron, Y., Fernandes, M., Duchemin-Pelletier, E., Michaud, J., Flaender, M., Lorintiu, O., Degot, S., & Poydenot, P. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218761102 · Cited by 41
Sha, Z., Zhao, J., & Goldberg, A. L. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8706-1_17 · Cited by 44
Self-citationSESN2 protects against denervated muscle atrophy through unfolded protein response and mitophagy
Yang, X., Xue, P., Yuan, M., Xu, X., Wang, C., Li, W., Machens, H., & Chen, Z. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04094-9 · Cited by 44
Sarcopenia is an Independent Prognostic Factor in Patients With Pancreatic Cancer – a Meta-analysis
Thormann, M., Hinnerichs, M. S., Ordonez, F. B., Saalfeld, S., Perrakis, A., Croner, R. S., Omari, J., Pech, M., Zamsheva, M., Meyer, H., et al. (2022) · Academic Radiology · doi:10.1016/j.acra.2022.10.025 · Cited by 48
Myotonic Dystrophy and Developmental Regulation of RNA Processing
Thomas, J. D., Oliveira, R., Sznajder, Ł. J., & Swanson, M. S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170002 · Cited by 54
Hughes, D. C., Goodman, C. A., Baehr, L. M., Gregorevic, P., & Bodine, S. C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00457.2023 · Cited by 46
Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia
Delitto, D., Judge, S. M., Delitto, A. E., Nosacka, R. L., Rocha, F. R. G., DiVita, B. B., Gerber, M. H., George, T. J., Behrns, K. E., Hughes, S. J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13593 · Cited by 44
van Roekel, E. H., Bours, M. J. L., Molder, M. E. M. T., Breedveld-Peters, J. J. L., Damink, S. W. M. O., Schouten, L. J., Sanduleanu, S., Beets, G. L., & Weijenberg, M. P. (2017) · Quality of Life Research · doi:10.1007/s11136-017-1539-z · Cited by 43
The final word on nutritional screening and assessment in older persons
Cereda, E., Veronese, N., & Caccialanza, R. (2018) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000431 · Cited by 40
Wang, B., Thapa, S., Zhou, T., Liu, H., Li, L., Peng, G., & Yu, S. (2019) · Supportive Care in Cancer · doi:10.1007/s00520-019-04717-0 · Cited by 47
Deng, C., Zhang, N., Wang, Y., Jiang, S., Lu, M. M., Huang, Y. J., Ma, J., Hu, C., & Hou, T. (2019) · Medicine · doi:10.1097/md.0000000000016875 · Cited by 41
Gold, S. L., Raman, M., Sands, B. E., Ungaro, R. C., & Sabino, J. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17498 · Cited by 47
Muscle wasting: emerging pathways and potential drug targets
Domaniku, A., Bilgiç, Ş. N., & Kır, S. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.07.006 · Cited by 42
Restricted Mouth Opening in Head and Neck Cancer: Etiology, Prevention, and Treatment
Abboud, W. A., Hassin‐Baer, S., Alon, E. E., Gluck, I., Dobriyan, A., Amit, U., Yahalom, R., & Yarom, N. (2020) · JCO Oncology Practice · doi:10.1200/op.20.00266 · Cited by 39
Longitudinal changes of frailty in 8 years: comparisons between physical frailty and frailty index
Hwang, A., Lee, W., Huang, N., Chen, L.-Y., Peng, L., Lin, M., Chou, Y., & Chen, L. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02665-1 · Cited by 46
Perry, B. D., Rahnert, J. A., Xie, Y., Zheng, B., Woodworth‐Hobbs, M. E., & Price, S. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191313 · Cited by 44
Lee, S.-J., Bae, J. H., Lee, H., Lee, H., Park, J., Kang, J.-S., & Bae, G.-U. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112054 · Cited by 38
da Rosa, T. H., Peterson, L., Bartikoski, B. J., Portes, J. K. S., Santo, R. C. D. E., & Xavier, R. M. (2022) · Arthritis Research & Therapy · doi:10.1186/s13075-022-02858-y · Cited by 44
Undernutrition and Intestinal Infections in Children: A Narrative Review
Carvalho, M. C. D. C., Ribeiro, S. A., de Sousa, L. S., Lima, A. Â. M., & Maciel, B. L. L. (2025) · Nutrients · doi:10.3390/nu17091479 · Cited by 67
Morel, J., Palao, J.-C., Castells, J., Desgeorges, M. M., Busso, T., Molliex, S. B., Jahnke, V. E., del Carmine, P., Gondin, J., Arnould, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11440-5 · Cited by 42
The Proteasome System in Health and Disease
Coux, O., Zieba, B. A., & Meiners, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_3 · Cited by 44
Metadata
- Authors
- Cohen, S., Nathan, J. A., & Goldberg, A. L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- University of Cambridge (GB)
- Harvard University (US)
- Corresponding author
- Cohen, Shenhav
- Goldberg, Alfred L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-12-31
- Volume
- 14
- Issue
- 1
- Pages
- 58-74
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1998867833
- Cited by
- 1,089
- References
- 257
- Citations by year
- 2026: 75 · 2025: 92 · 2024: 92 · 2023: 111 · 2022: 110 · 2021: 111 · 2020: 117 · 2019: 88 · 2018: 91 · 2017: 86 · 2016: 79 · 2015: 36
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100140, 102770, 102770/Z/13/Z)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055255, R01AR055255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- muscle atrophy, sarcopenia, cancer cachexia, sepsis, denervation, immobilization, protein synthesis, protein degradation, myostatin, cytokines, exercise therapy, therapeutic agents, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, heart failure, Cushing's syndrome
- MeSH terms
- Animals, Humans, Muscular Atrophy, Myofibrils, Quality of Life, Signal Transduction, Sepsis, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.